Blog Band - Page 252 of 266

Insights+ Key Biosimilars Events of August 2020

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency Mylan with its partner Lupin and Biocon launched Nepexto (biosimilar, etanercept) and Semglee (insulin glargine injection) in Germany & in the US, respectively. Additionally, Formycon and Bioeq planned to initiate P-III MAGELLAN-AMD Trial for its FYB203 (biosimilar,…

BySenior EditorSeptember 3, 20200Comments

INSIGHTS+

Insights+: The US FDA New Drug Approvals in July 2020

The US FDA has approved multiple NDAs and BLAs in July 2020, leading to treatments for patients and advances in the health care industry. The Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) have approved 59 novel products so far in 2020, including 8 in July 2020. Additionally,…

BySenior EditorAugust 27, 20200Comments

THOUGHTSPOT

Medical Representatives Opinion Survey for Business Continuity with New Normal

K. K. Consulting Services has conducted this survey by contacting around 2200 medical representatives across the India using google forms. Objective of Survey The purpose of this survey is to design a platform for pharmaceutical sales professionals (PSP) to share their opinion about business continuity challenges faced by them due to the present COVID pandemic situation. The nature…

BySenior EditorAugust 24, 20200Comments

TOP 20

Top 20 Innovative Digital Therapeutics Companies of 2019

The recent decades have shown an accelerated development and evolution in the technology world- leading to unexpected growth in digital health companies. With the aid of health information technology- wearable devices- telehealth- telemedicine- and personalized medicine HCPs can make better insights for treatments and early diagnosis of life-threatening diseases Our team at PharmaShots has categorized…

ByPrince GiriAugust 14, 20200Comments

THOUGHTSPOT

COVID-19 Vaccine Distribution the Next Supply Chain Frontier

An overview of various aspects of the supply chain that would be crucial in the production and distribution of COVID-19 Vaccine. Write to us at connect@pharmashots.com if you want a PDF copy of this report. Over the past seven months, the global pandemic caused by the spread of SARS-CoV-2, the virus that leads to coronavirus disease (COVID-19),…

BySenior EditorAugust 13, 20200Comments

THOUGHTSPOT

Revised approach for First Aid during and after the Catastrophic Pandemic Safe and Saving

The SARS CoV-2 or COVID-19 pandemic has changed human life permanently. Hence, a few critical areas need revisiting in light of these changes to set a 'new normal' for them. One of such areas is first aid. Correctly given first aid helps the victim of an emergency episode of a disease or an accident prevents…

ByAshish IndaniAugust 12, 20200Comments

INSIGHTS+

Insights+ Key Biosimilars Events of July 2020

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency Cadila expanded its footprints in India with the launch of its two biosimilars Bevaro (bevacizumab, biosimilar) and Ritucad (rituximab, biosimilar) Our team at PharmaShots has summarized 9 key events of the biosimilar space of July 2020 1. Samsung…

BySenior EditorAugust 7, 20200Comments

THOUGHTSPOT

The New Normal and Covid-19 Vaccine Development

Since the virus outbreak in China, all eyes are on the most awaited Covid-19 vaccine offering a glimmer of hope. Abide by social distancing, wearing a mask, and frequent hand washing - until we have a vaccine. This new mantra amidst all misery has created hope in the hearts of many. We have to accept…

BySenior EditorAugust 5, 20200Comments

EVENTS

Exclusive Webinar: Deal And Venture Trends Through The First Half Of 2020

On September 2, 2020, Octavus Consulting and DealForma will present their most recent data and trends on dealmaking across biopharma, device, diagnostics, and digital health. Healthcare and life sciences deal and venture activity through August 2020 has not slowed down despite the challenges thrown at business leaders globally. We will review recent trends covering the…

BySenior EditorAugust 1, 20200Comments

Insights+ Key Biosimilars Events of August 2020

Insights+: The US FDA New Drug Approvals in July 2020

Medical Representatives Opinion Survey for Business Continuity with New Normal

Top 20 Innovative Digital Therapeutics Companies of 2019

COVID-19 Vaccine Distribution the Next Supply Chain Frontier

Revised approach for First Aid during and after the Catastrophic Pandemic Safe and Saving

Insights+ Key Biosimilars Events of July 2020

The New Normal and Covid-19 Vaccine Development

Exclusive Webinar: Deal And Venture Trends Through The First Half Of 2020

Contact US

OUR INFORMATION

FOLLW US

FOLLW US

Sign Up to Our Newsletter